COMMUNIQUÉS West-GlobeNewswire

Progressive Care Releases Investor Presentation
03/04/2018
MIAMI, April 03, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announced that is has released its investor presentation for public view. The Company has [...]
Shire plc : Director/PDMR Shareholding
03/04/2018
Director/PDMR Shareholding April 3, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transactions by persons discharging managerial responsibilities 1. Details of the person discharging managerial [...]
Canada House Announces Third Quarter Fiscal 2018 Results
03/04/2018
Cash Position Improves to $10.9 million, up from $0.7 million as at April 30, 2017 Shareholders Equity improves to $8.2 million compared to a deficit of $1.2 million as at April 30, 2017 NOT FOR DISTRIBUTION TO U.S. [...]
Androvia LifeSciences Study Reveals New Evidence for Men Experiencing Fertility Problems
03/04/2018
Timing for Sperm Maturation and Capacitation Differs Dramatically in Men MOUNTAINSIDE, N.J., April 03, 2018 (GLOBE NEWSWIRE) -- Androvia LifeSciences , a company dedicated to the development of male fertility solutions [...]
Symphony Health’s New Enhanced Views Program Expands Evidence-Driven Insights
03/04/2018
Enhanced panel provides expanded insights across multiple information assets and offers new insight to patient activity and the treatment journey CONSHOHOCKEN, Pa., April 03, 2018 (GLOBE NEWSWIRE) -- Symphony Health , a [...]
Adamas Announces First Patient Enrolled in Phase 3 Trial of ADS-5102 in Multiple Sclerosis Patients with Walking Impairment
03/04/2018
EMERYVILLE, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that the first patient has been enrolled in its pivotal Phase 3 clinical trial of ADS-5102 (amantadine [...]
WellDoc Announces Providence Health & Services’ Implementation of BlueStar® Digital Therapeutic in a Pilot Program for Individuals with Type 2 Diabetes
03/04/2018
COLUMBIA, Md., April 03, 2018 (GLOBE NEWSWIRE) -- Today, WellDoc ® announced a pilot program in the Providence Health & Services Oregon/SW Washington Region to examine the use of WellDoc’s BlueStar ® , an FDA- [...]
AXIM Biotech Reaches Preliminary Agreement for Distribution of CanChew and MedChew Products Throughout South Korea
03/04/2018
NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (AXIM ® Biotech) (OTCQB:AXIM), a world leader in cannabinoid research and development, today announced that it has entered into a Memo of [...]
Ceapro Announces Acceptance of Abstract for Presentation at the Nutrition 2018 Meeting
03/04/2018
EDMONTON, Alberta, April 03, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO ) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients [...]
NewLink Genetics Announces Participation at The H.C. Wainwright Annual Global Life Sciences Conference
03/04/2018
AMES, Iowa, April 03, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) announced today it will present at the H. C. Wainwright Annual Global Life Sciences Conference. The conference is being held on [...]
ProLynx extends lead in half-life extension platform technology – Shows primary deuterium kinetic isotope effects prolong drug release and polymer biodegradation in a drug delivery system
03/04/2018
SAN FRANCISCO, April 03, 2018 (GLOBE NEWSWIRE) -- ProLynx announced today the publication of a paper demonstrating its leading capabilities to exploit primary deuterium kinetic isotope effects (1°DKIEs) for prolonging [...]
Q-Centrix Solution Among First to Be Certified for CathPCI v5 Reporting
03/04/2018
With the new certification, Q-Centrix continues to lead the way in providing comprehensive solutions for participation in major cardiac-care registries Chicago, April 03, 2018 (GLOBE NEWSWIRE) -- Q-Centrix adds [...]
Wildflower Secures $720,000 Purchase Order
03/04/2018
VANCOUVER, British Columbia, April 03, 2018 (GLOBE NEWSWIRE) -- Wildflower Marijuana Inc. (CSE:SUN) (FWB:RSP) (“Wildflower” or the "Company") has received its first purchase order pursuant to the recently announced [...]
CURE Pharmaceutical Reports Strong Progress and Sets Growth Roadmap for Remainder of Year
03/04/2018
OXNARD, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery company, today reported the company’s Q1 2018 accomplishments. The company strengthened its leadership team [...]
UroGen Pharma Announces Presentation of Results from Interim Analysis of Pivotal Phase 3 OLYMPUS Trial of UGN-101 (MitoGel™) for Non-Surgical Treatment of Upper Tract Urothelial Cancer (UTUC)
03/04/2018
RA’ANANA, Israel and NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with [...]
Terveystalo Plc: Lääkäriasema ILO to become a part of Terveystalo
03/04/2018
Terveystalo has acquired Lääkäriasema ILO (Juha Uusimäki Oy) on 29 March 2018. The company operates clinics in Tuuri and Vimpeli. The company's personnel will be transferred to Terveystalo as old employees and [...]
Cesca Therapeutics Inc. Announces Release of X-Mini™ Cell Selection Kit for the CAR-T Research Market
03/04/2018
RANCHO CORDOVA, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today [...]
ChemoCentryx to Present at Two Upcoming Investor Conferences
03/04/2018
MOUNTAIN VIEW, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI ), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at two upcoming investor [...]
Bellerophon Therapeutics to Provide Corporate Update at H.C. Wainwright Annual Global Life Sciences Conference
03/04/2018
WARREN, N.J., April 03, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH ) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that Fabian Tenenbaum, [...]

Pages